Table 1.

Structures, epitopes, mechanisms of action and routes of administration of anti-CD20 monoclonal antibodies approved for or under clinical investigation for use in MS

^aInformation is not currently publicly available

ADCC antibody-dependent cellular cytotoxicity, CD cluster of differentiation, CDC complement-dependent cytotoxicity, MS multiple sclerosis, N/a not available